TESTOSTERON DEPO 250mg/ml Rastvor za injekciju Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

testosteron depo 250mg/ml rastvor za injekciju

"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, budva - testosteron - rastvor za injekciju - 250mg/ml

Androgel 50 mg transdermalni gel u vrećici Horvātija - horvātu - HALMED (Agencija za lijekove i medicinske proizvode)

androgel 50 mg transdermalni gel u vrećici

besins healthcare s.a., rue washington 80, ixelles, belgija - testosteron - transdermalni gel u vrećici - 50 mg - urbroj: jedna vrećica (5 g gela) sadrži 50 mg testosterona

Testarzon 20 mg/g transdermalni gel Horvātija - horvātu - HALMED (Agencija za lijekove i medicinske proizvode)

testarzon 20 mg/g transdermalni gel

the simple pharma company limited, ground floor, 71 lower baggot st, dublin, irska - testosteron - transdermalni gel - 20 mg/g - urbroj: jedan gram gela sadrži 20 mg testosterona jedan potisak na pumpici istiskuje 1,15 g (1,25 ml) gela što odgovara 23 mg testosterona

Nebido 1000 mg/4 ml otopina za injekciju Horvātija - horvātu - HALMED (Agencija za lijekove i medicinske proizvode)

nebido 1000 mg/4 ml otopina za injekciju

bayer d.o.o., radnička cesta 80, zagreb, hrvatska - testosterondekanoat - otopina za injekciju - 1000 mg/4 ml - urbroj: 1 ml otopine za injekciju sadrži 250 mg testosteron undekanoata što odgovara 157,9 mg testosterona

NEBIDO 1000mg/4ml Rastvor za injekciju Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

nebido 1000mg/4ml rastvor za injekciju

"evropa lek pharma" doo podgorica - testosteron - rastvor za injekciju - 1000mg/4ml

NEBIDO 1000mg/4ml Rastvor za injekciju Melnkalne - horvātu - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

nebido 1000mg/4ml rastvor za injekciju

društvo za trgovinu, promet i usluge "farmegra" d.o.o. podgorica - testosteron - rastvor za injekciju - 1000mg/4ml

Firmagon Eiropas Savienība - horvātu - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostatske neoplazme - endokrinska terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Degarelix Accord Eiropas Savienība - horvātu - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatske neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.